What Happened?
, -based Acelyrin Appointed Gil Labrucherie as Chief Financial Officer
About the Company
Acelyrin, INC. (Nasdaq: SLRN) is a Los Angeles area-based late-stage clinical biopharma company – with additional operations in the San Francisco Bay area – focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising product candidates. Acelyrin is embedding a corporate culture of Courageous Caring™ -- placing patients first and embracing the concept that all of us are better than any one of us -- as we seek to addresses the most basic human needs: to live a productive life free from diseases.
About the Person
Gil Labrucherie is Chief Financial Officer at Acelyrin. Previously, Gil held various senior HR leadership roles in the industry.
Info Source
News
Short Profile